Table 3.

The effects of nuciferine treatment on cholesterol metabolism in liver cells (mRNA analysis).

Treatment	LDL-R	HMG-CoAR	CYP7A1	ACAT2
No nuciferine	1	1	1	1
Nuciferine: low dose	1.86 ± 0.84**	2.18 ± 0.26**	0.94 ± 0.17	0.97 ± 0.24
Nuciferine: medium dose	2.95 ± 0.25**	2.58 ± 0.14**	0.93 ± 0.26	0.95 ± 0.28
Nuciferine: high dose	3.57 ± 1.01**	2.96 ± 0.25**	1.15 ± 0.31	0.78 ± 0.19**
Atorvastatin	5.83 ± 0.19**	6.58 ± 0.28**	1.29 ± 0.12*	0.49 ± 0.33**

Note: comparison with no-drug control group, *P < 0.05, **P < 0.01.